Chida Rie, Morichi Shinichiro, Watanabe Yusuke, Yamanaka Gaku
Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo, JPN.
Cureus. 2022 Nov 5;14(11):e31138. doi: 10.7759/cureus.31138. eCollection 2022 Nov.
Bacterial meningitis in infants is a life-threatening illness that survives significant neurological sequelae that remain in survivors. The current diagnostic gold standard for meningitis is bacterial isolation from culture or molecular diagnostics in the cerebrospinal fluid. The decision for antibiotics therapy before bacterial detection is made on microscopic and biochemical findings in the cerebrospinal fluid, however, some patient shows no microscopic finding and pleocytosis at the initial cerebrospinal fluid analysis. Herein, we report a case of late-onset group B serotype Ib meningitis that could be introduced with timelier antibiotic therapy even in the absence of pleocytosis without the detection of bacteria on smear at the initial CSF analysis.
婴儿细菌性脑膜炎是一种危及生命的疾病,幸存者会留下严重的神经后遗症。目前脑膜炎的诊断金标准是从脑脊液培养物中分离细菌或进行分子诊断。在检测到细菌之前,根据脑脊液的显微镜和生化检查结果决定是否进行抗生素治疗,然而,一些患者在最初的脑脊液分析中没有显微镜下发现和细胞增多现象。在此,我们报告一例迟发性B族血清型Ib脑膜炎病例,即使在最初的脑脊液分析中没有细胞增多且涂片未检测到细菌的情况下,也可及时进行抗生素治疗。